Distribution of the number of EBV genomes per cell
Patient . | Diagnosis . | EBV DNA load/106 cells . | % of range of EBV genomes per cell . | Total EBV+ cells counted . | |||
---|---|---|---|---|---|---|---|
1-10 . | 11-20 . | 21-30 . | > 30 . | ||||
1 | HIV | 12 000 | 10 | 30 | 40 | 20 | 10 |
2 | HIV | 4300 | 34 | 44 | 22 | 0 | 9 |
3 | HIV | 18 000 | 31 | 31 | 38 | 0 | 13 |
4 | HIV | 130 000 | 50 | 38 | 4 | 8 | 24 |
5 | HIV | 9400 | 75 | 25 | 0 | 0 | 4 |
6 | HIV | 5100 | 43 | 43 | 7 | 7 | 14 |
7 | HIV | 22 000 | 58 | 42 | 0 | 0 | 19 |
8 | HIV | 6300 | 25 | 38 | 25 | 12 | 16 |
9 | Tx | NA | 75 | 25 | 0 | 0 | 4 |
10 | Tx | 30 000 | 54 | 38 | 8 | 0 | 24 |
11 | Tx | 6200 | 40 | 40 | 20 | 0 | 10 |
12 | LyG/HL | 170 000 | 64 | 27 | 6 | 3 | 77 |
13 | Severe primary EBV infection | 280 000 | 27 | 54 | 11 | 8 | 37 |
14 | PTLD | 1 300 000 | 36 | 29 | 9 | 16 | 33 |
15 | ATL EBV-LPD | 190 000 | 48 | 44 | 4 | 4 | 25 |
16 | LyG | 28 000 | 70 | 25 | 0 | 5 | 20 |
17 | ICL | 110 000 | 45 | 31 | 21 | 3 | 38 |
18 | AA | 64 000 | 69 | 23 | 8 | 0 | 13 |
19 | AA | 110 000 | 46 | 21 | 25 | 8 | 24 |
20 | AA | 6 500 000 | 36 | 37 | 18 | 9 | 55 |
21 | B-cell CAEBV | 15 000 | 65 | 30 | 5 | 0 | 20 |
22 | B-cell CAEBV | 30 900 | 31 | 54 | 9 | 6 | 35 |
23 | B-cell CAEBV | 310 000 | 54 | 33 | 13 | 0 | 15 |
24 | T-cell CAEBV | 54 666/μg | 75 | 24 | 1 | 0 | 88 |
25 | T-cell CAEBV | 67 612/μg | 71 | 29 | 0 | 0 | 21 |
26 | T-cell CAEBV | 230 000/μg | 56 | 41 | 3 | 0 | 78 |
27 | T-cell CAEBV | 4154/μg | 54 | 39 | 7 | 0 | 18 |
28 | IM | 1700 | 65 | 29 | 6 | 0 | 17 |
29 | IM | 10 651 | 57 | 29 | 14 | 0 | 14 |
Patient . | Diagnosis . | EBV DNA load/106 cells . | % of range of EBV genomes per cell . | Total EBV+ cells counted . | |||
---|---|---|---|---|---|---|---|
1-10 . | 11-20 . | 21-30 . | > 30 . | ||||
1 | HIV | 12 000 | 10 | 30 | 40 | 20 | 10 |
2 | HIV | 4300 | 34 | 44 | 22 | 0 | 9 |
3 | HIV | 18 000 | 31 | 31 | 38 | 0 | 13 |
4 | HIV | 130 000 | 50 | 38 | 4 | 8 | 24 |
5 | HIV | 9400 | 75 | 25 | 0 | 0 | 4 |
6 | HIV | 5100 | 43 | 43 | 7 | 7 | 14 |
7 | HIV | 22 000 | 58 | 42 | 0 | 0 | 19 |
8 | HIV | 6300 | 25 | 38 | 25 | 12 | 16 |
9 | Tx | NA | 75 | 25 | 0 | 0 | 4 |
10 | Tx | 30 000 | 54 | 38 | 8 | 0 | 24 |
11 | Tx | 6200 | 40 | 40 | 20 | 0 | 10 |
12 | LyG/HL | 170 000 | 64 | 27 | 6 | 3 | 77 |
13 | Severe primary EBV infection | 280 000 | 27 | 54 | 11 | 8 | 37 |
14 | PTLD | 1 300 000 | 36 | 29 | 9 | 16 | 33 |
15 | ATL EBV-LPD | 190 000 | 48 | 44 | 4 | 4 | 25 |
16 | LyG | 28 000 | 70 | 25 | 0 | 5 | 20 |
17 | ICL | 110 000 | 45 | 31 | 21 | 3 | 38 |
18 | AA | 64 000 | 69 | 23 | 8 | 0 | 13 |
19 | AA | 110 000 | 46 | 21 | 25 | 8 | 24 |
20 | AA | 6 500 000 | 36 | 37 | 18 | 9 | 55 |
21 | B-cell CAEBV | 15 000 | 65 | 30 | 5 | 0 | 20 |
22 | B-cell CAEBV | 30 900 | 31 | 54 | 9 | 6 | 35 |
23 | B-cell CAEBV | 310 000 | 54 | 33 | 13 | 0 | 15 |
24 | T-cell CAEBV | 54 666/μg | 75 | 24 | 1 | 0 | 88 |
25 | T-cell CAEBV | 67 612/μg | 71 | 29 | 0 | 0 | 21 |
26 | T-cell CAEBV | 230 000/μg | 56 | 41 | 3 | 0 | 78 |
27 | T-cell CAEBV | 4154/μg | 54 | 39 | 7 | 0 | 18 |
28 | IM | 1700 | 65 | 29 | 6 | 0 | 17 |
29 | IM | 10 651 | 57 | 29 | 14 | 0 | 14 |
Additional cell subsets (eg, “non-T, non-NK, non-monocytes”) that are not represented in Tables 1 and 2 are included in the counts for this table.